ResMed Inc. announced its financial results for the first quarter of fiscal year 2027 ended September 30, 2026. The company ...

"During the first quarter of our fiscal year 2027, we delivered another strong set of results. 7% revenue growth on a core constant currency basis on the top line, 50 basis points of year-over-year ...

<?xml encoding="utf-8" ?> ResMed RMD reported first-quarter financial results on Thursday. The transcript from the company’s ...

Q1 revenue increased by 6% to $1.4 billion; up 7% on a core constant currency basisQ1 GAAP diluted earnings per share up 23% to $2.92; non-GAAP ...

ResMed reported first-quarter fiscal 2027 results with revenue of $1.4 billion, up 6% year-over-year and 7% on a core constant currency ...

Resmed Inc. Reports Q1 Revenue $1.41B, vs. FactSet Est of $1.39B MT 04:19pm Earnings Flash (RMD) Resmed Inc. Posts Q1 ...

When sleep apnea is diagnosed through polysomnography, CPAP therapy is usually recommended. The problem is that many patients ...

Why it matters: We see GLP-1s as a headwind, but not an existential threat. Sleep apnea is driven by age, sex, and anatomy as well as weight, so remission after major weight loss is usually partial.

Resmed Inc. develops cloud-connected devices, masks and software used in sleep-disordered breathing and home healthcare. On, Resmed (ASX:RMD) was quoted at AUD 35.975, up 0.18% during the trading ...

A robot vacuum just does it while you’re asleep, and my pick for people managing depression is the eufy RoboVac G10 Hybrid.

Resmed (NYSE: RMD) has launched the AirTouch F40, a full-face, fabric CPAP mask designed to be more comfortable for sleep ...

ResMed has launched the AirTouch F40 CPAP mask in the U.S., a fabric-cushioned, minimalist design that connects into its ...